No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

Medicare Claims for Duplicate Laboratory Services Continue to Be Denied

Medicare Claims for Duplicate Laboratory Services Continue to Be Denied

The Centers for Medicare & Medicaid Services (CMS) says it will continue to deny claims for duplicate laboratory services unless the tests are deemed...

Read More
CAP Submits Comments on Proposed 2027 Medicare Physician Fee Schedule

CAP Submits Comments on Proposed 2027 Medicare Physician Fee Schedule

The College of American Pathologists (CAP) submitted comments to the proposed 2027 Medicare Physician Fee Schedule (PFS), addressing proposals that...

Read More
CMS Announces Phased-In Reduction of Medicare Payment Rates for Lab Services

CMS Announces Phased-In Reduction of Medicare Payment Rates for Lab Services

The Centers for Medicare & Medicaid Services (CMS) plans to reduce preliminary Medicare payment rates for laboratory services.

Read More